BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6973851)

  • 1. Immunosuppressive activity of monoclonal anti-thy-1.2: comparison of monoclonal IgM and IgG with xeno-antithymocyte preparations.
    Sherburne CG; Condie RM
    Transplant Proc; 1981 Mar; 13(1 Pt 1):504-8. PubMed ID: 6973851
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of five cloned murine cell lines showing high cytolytic activity against YAC-1 cells.
    Brooks CG; Kuribayashi K; Sale GE; Henney CS
    J Immunol; 1982 May; 128(5):2326-35. PubMed ID: 6174628
    [No Abstract]   [Full Text] [Related]  

  • 3. Antilymphocytic antibodies and marrow transplantation: ATG suppresses antiantibody formation against monoclonal anti-T-cell antibodies.
    Thierfelder S; Kremmer E; Lederer R; Kummer U
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3055-7. PubMed ID: 2650423
    [No Abstract]   [Full Text] [Related]  

  • 4. [Monoclonal antibodies from the hybridization of lymphocytes].
    Ax W
    Ric Clin Lab; 1983; 13 Suppl 2():1-9. PubMed ID: 6366991
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between Fc (IgG) receptors and alloantigens on the surface of BALB/c B cell lymphoma lines.
    Kanellopoulos-Langevin C; Kim KJ; Sachs DH; Asofsky R
    J Immunol; 1979 Dec; 123(6):2651-7. PubMed ID: 501085
    [No Abstract]   [Full Text] [Related]  

  • 6. [Classes of immunoglobulins responsible for serum antithymocyte activity in healthy subjects and mental pathology].
    Kushner SG; Maznina TP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1014-5. PubMed ID: 7027698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repertoire diversification in mice with an IgH-locus-targeted transgene for the rearranged VH domain of a physiologically selected anti-ssDNA antibody.
    Li J; Geissal ED; Li W; Stollar BD
    Mol Immunol; 2005 Aug; 42(12):1475-84. PubMed ID: 15950740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse T cell-mediated cytolysis specifically triggered by cytophilic xenogeneic serum determinants: a caveat for the interpretation of experiments done under "syngeneic" conditions.
    Golstein P; Luciani MF; Wagner H; Röllinghoff M
    J Immunol; 1978 Dec; 121(6):2533-8. PubMed ID: 82588
    [No Abstract]   [Full Text] [Related]  

  • 9. IgM but not IgG monoclonal anti-Nocardia brasiliensis antibodies confer protection against experimental actinomycetoma in BALB/c mice.
    Gonzalez-Suarez ML; Salinas-Carmona MC; Pérez-Rivera I
    FEMS Immunol Med Microbiol; 2009 Oct; 57(1):17-24. PubMed ID: 19624737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of major histocompatibility complex (MHC) to upregulation of anti-DNA antibody in transgenic mice.
    Song YW; Tsao BP; Hahn BH
    J Autoimmun; 1993 Feb; 6(1):1-9. PubMed ID: 8457281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive effects of cannabidiol on antigen-specific antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB/c mice.
    Jan TR; Su ST; Wu HY; Liao MH
    Int Immunopharmacol; 2007 Jun; 7(6):773-80. PubMed ID: 17466911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterization of an (NZB x NZW)F1 mouse-derived IgM monoclonal antibody that binds through V region-dependent interactions to murine IgG anti-DNA antibodies.
    Margaritte C; Gilbert D; Brard F; Tron F
    J Autoimmun; 1994 Dec; 7(6):711-25. PubMed ID: 7888030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. III. Autoantibodies to thymocytes.
    van der Veen JP; Rolink AG; Gleichmann E
    J Immunol; 1981 Oct; 127(4):1281-6. PubMed ID: 6974187
    [No Abstract]   [Full Text] [Related]  

  • 14. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of immune responses by anti-idiotypic lymphocytes].
    Miura T
    Rinsho Byori; 1982 Jul; 30(7):749-57. PubMed ID: 6983593
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
    Hamano K; Morris PJ; Wood KJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of antithymocyte serum on reaginic antibody formation in the rat.
    Okumura K; Tada T; Ochiai T
    Immunology; 1974 Feb; 26(2):257-68. PubMed ID: 4546784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of anti-T-lymphocyte monoclonal antibody (5G2) therapy for prolongation of canine islet allograft survival.
    Brendel MD; Schachner RS; Kong SS; Qian T; Alejandro R; Mintz DH
    Transplant Proc; 1994 Apr; 26(2):743-4. PubMed ID: 8171637
    [No Abstract]   [Full Text] [Related]  

  • 19. Acceptor site(s) for T cell-replacing factor (TRF) on B lymphocytes. II. Activation of B cells by cross-linkage or aggregation of the TRF acceptor molecule.
    Tominaga A; Takatsu K; Hamaoka T
    J Immunol; 1982 Jun; 128(6):2581-5. PubMed ID: 6978908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses of tumor-bearing mice to their own tumors captured and perpetuated as hybridomas.
    Simrell CR; Klein PA
    J Immunol; 1979 Nov; 123(5):2386-94. PubMed ID: 226630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.